Urolog. pro Praxi, 2010; 11(2): 108-109
Adverse effects of medicinal products - why deal with them ?
- Státní ústav pro kontrolu léčiv, Oddělení farmakovigilance, Praha
The risk of developing adverse effects can be associated with the administration of any pharmacotherapy. Adverse effects occur in
1.7 % to 6.7 % of hospitalized patients. Those occurring frequently can be and are studied in preregistration clinical trials. Yet, some adverse
effects remain unrecognized at the time of registration. Thus, health care professionals become the key source of information on
adverse effects following the introduction of a medicinal product in clinical practice. With their help, it is possible to identify drug-related
risks that have not been described so far. Any suspicion of an adverse effect of a medicinal product is reported to the State Institute for
Drug Control where these reports are collected and evaluated, and, if necessary, health care professionals are informed of newly found
risks and the possibilities of how to prevent them.
Keywords: adverse effects, adverse effects reporting, adverse effects classification
Published: May 1, 2010 Show citation
